OSE Pharma SA

Research OSE Pharma SA (OSE) on Bullrun: market cap EUR 74.54M. Explore financials, valuation history, model signals, and stock context.

Key Metrics

• TickerOSE
• ExchangePA
• CountryFrance
• SectorHealthcare
• IndustryBiotechnology
• CurrencyEUR
• Market capEUR 74.54M
• Financial periodFY2024
• RevenueEUR 69.88M
• Revenue growth3037.7%
• Net incomeEUR 37.45M
• Free cash flowEUR 48.36M

Valuation Snapshot

latest market cap is EUR 74.54M.

About OSE Pharma SA

OSE Immunotherapeutics SA, a clinical-stage biotechnology company, develops immunotherapies in the areas of immune-oncology and immune-inflammation in France and internationally. The company's products include Tedopi that is in Phase III clinical trial for the treatment of non-small cell lung cancer, as well as in Phase II clinical trial to pancreatic and ovarian cancer; OSE-279, which is in a Phase I/II clinical trial in patients with advanced solid tumors or lymphomas;

Frequently asked questions

What is OSE Pharma SA's market cap?

OSE Pharma SA's market capitalization is EUR 74.54M.

What does OSE Pharma SA do?

OSE Immunotherapeutics SA, a clinical-stage biotechnology company, develops immunotherapies in the areas of immune-oncology and immune-inflammation in France and internationally.